This article has been corrected to note that Helicos expects the revenue to be recognized in the fourth quarter of 2009 and first quarter of 2010, rather than in its third quarter of 2009.

NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it expects to report cash receipts of $5 million from systems orders and associated reagent purchases during the fourth quarter of 2009 and first quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.